A Study To Assess The Safety And Effectiveness Of The UrOActive® Artificial Urinary SPHincter (AUS)

Overview

About this study

Prospective, multicenter, single-arm study

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Key Inclusion Criteria:

* Male subjects aged ≥ 22 years old
* Able to read, comprehend and willing to sign an informed consent form
* Primary diagnosis of stress urinary incontinence for at least 6 months, as assessed by the investigator
* Appropriate surgical candidate with no medical or mental condition that would interfere with study procedures or confound study outcomes as assessed by the investigator

Key Exclusion Criteria:

* Currently enrolled or plans to enroll in another investigational device or clinical drug trial or has completed an investigational study (for urinary incontinence) in the past 3 months prior to informed consent
* Poor candidate for surgical procedures and/or anesthesia, as determined by investigator
* Currently implanted with an Active Implantable Medical Device (AIMD)
* Symptoms or diagnosis of urge incontinence or mixed incontinence (MI) with a predominant urgency component, as assessed by the investigator

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Daniel Elliott

Open for enrollment

Contact information:

Wyatt Anians

(507) 538-6151

anians.wyatt@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597224

Mayo Clinic Footer